Form D · Other Health Care
OxyDial Inc
Philadelphia, PA · CIK 0002126739
Offering snapshot reported May 20, 2026 · SEC filing
- Reported sold
- $700K Offering amount: $1.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2026 | Initial | $700,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584602
The total offering amount excludes the conversion of outstanding convertible indebtedness previously issued by the Issuer.
Source: Form D, filed May 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Albert | Director |
| Alexey Aprelev | Director, Executive |
| Oleksandr Shestakov | Director, Executive, Promoter |
| John Yapaola | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
50 S. 16th Street, Ste. 1800
Philadelphia, PA, 19102
Philadelphia, PA, 19102